Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07489053 · ClinicalTrials.gov registry record · NA
Optimizing Functional Recovery After Breast Cancer Treatment
A NA study, sponsored by MGH Institute of Health Professions.
- Not yet
- Registry status
- NA
- Development phase
- 352
- Enrollment target
NCT07489053 is a NA study that has not yet begun recruiting, run by MGH Institute of Health Professions. The registered enrollment target is 352 participants.
The verdict
NCT07489053, a NA study, has not yet begun recruiting, sponsored by MGH Institute of Health Professions.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 352 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to determine the best way to promote participation in vocational, social, physical, and instrumental activities of daily living in people who have completed treatment for early stage breast cancer. The main question it aims to answer is: Which of the intervention components, alone or in combination, most effectively promote participation in vocational, social, physical, and instrumental activities of daily living? Participants will be asked to try one of 8 combination of three intervention components that have been shown to promote activity participation: (1) priority elicitation, (2) education, and (3) guided application involving goal setting, problem-solving and action planning.
Interventions
- BEHAVIORAL Individually tailored education and guided application to promote activity participation
- BEHAVIORAL Individually tailored guided application
- BEHAVIORAL Individually tailored education
- BEHAVIORAL Priority elicitation
- BEHAVIORAL Static education and guided application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 352 participants |
| Start Date | 2027-01-01 |
| Est. Completion | 2030-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07489053
The ClinicalTrials.gov registry entry for NCT07489053 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 352 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MGH Institute of Health Professions, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Individually tailored education and guided application to promote activity participation is the first listed.
NCT07489053 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07489053 about?
NCT07489053 is a clinical study titled "Optimizing Functional Recovery After Breast Cancer Treatment". The goal of this clinical trial is to determine the best way to promote participation in vocational, social, physical, and instrumental activities of daily living in people who have completed treatment for early stage breast cancer. The main question it aims to answer is: Which of the intervention ...
What is the current status of trial NCT07489053?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 352 participants. The study started on 2027-01-01. Estimated completion is 2030-09-30.
What interventions are being tested in trial NCT07489053?
The interventions under investigation include: Individually tailored education and guided application to promote activity participation (BEHAVIORAL), Individually tailored guided application (BEHAVIORAL), Individually tailored education (BEHAVIORAL), Priority elicitation (BEHAVIORAL), Static education and guided application (BEHAVIORAL).
Who is sponsoring clinical trial NCT07489053?
This trial is sponsored by MGH Institute of Health Professions, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.